Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of LifeM.H. Cullen, R L Souhami, N.H. Gower et al.|Journal of Clinical Oncology|1999Cited by 449
Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statementSarah P. Blagden, A. Yiangou, Lucinda Billingham et al.|British Journal of Cancer|2020Cited by 44